Cargando…
Magnesium in chronic haemodialysis (MAGIC-HD): a study protocol for a randomised controlled trial to determine feasibility and safety of using increased dialysate magnesium concentrations to increase plasma magnesium concentrations in people treated with haemodialysis
INTRODUCTION: People treated with haemodialysis are at increased risk for all-cause and cardiovascular mortality. Plasma magnesium concentration has been inversely associated with these risks. Therefore, plasma magnesium may be a new modifiable risk factor and an increase of dialysate magnesium conc...
Autores principales: | Leenders, Nicoline H J, Douma, Caroline E., Hoenderop, Joost G.J., Vervloet, Marc G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9680141/ https://www.ncbi.nlm.nih.gov/pubmed/36410806 http://dx.doi.org/10.1136/bmjopen-2022-063524 |
Ejemplares similares
-
Magnesium: A Magic Bullet for Cardiovascular Disease in Chronic Kidney Disease?
por: Leenders, Nicoline H. J., et al.
Publicado: (2019) -
Routine hemodialysis induces a decline in plasma magnesium concentration in most patients: a prospective observational cohort study
por: Leenders, Nicoline H. J., et al.
Publicado: (2018) -
Reduced Mortality in Maintenance Haemodialysis Patients on High versus Low Dialysate Magnesium: A Pilot Study
por: Schmaderer, Christoph, et al.
Publicado: (2017) -
Dietary magnesium supplementation inhibits abdominal vascular calcification in an experimental animal model of chronic kidney disease
por: Leenders, Nicoline H J, et al.
Publicado: (2022) -
Impact of cetuximab conventional dosing on cetuximab-induced magnesium concentration under haemodialysis in head and neck cancer
por: Thariat, Juliette, et al.
Publicado: (2008)